Desktop Site
|
23 Apr 24 | 16:00
|
Close
Equity
SME
Eq Drv
Currency
Commodity
Corporates
Get Quote
*
Notices
|
S&P
BSE SENSEX
73,738.45
+89.83
+0.12 %
Corporate Announcement
Security Code
531633
Company
LINCOLN PHARMACEUTICALS LTD.
Exchange Received Time
14/11/2019 13:57:35
Exchange Disseminated Time
14/11/2019 13:59:04
Time Taken
00:01:29
For Considered And Approved Un-Audited Financial Results For The Quarter And Half Year Ended On September 30, 2019 |
11/14/2019 1:58:58 PM
we would like to inform that the Board of Directors of the Company at their meeting held today, i.e. on November 14, 2019 had considered following:
1. To Considered and Approved Un-Audited Standalone and Consolidated Financial Results for the Quarter and Half Year Ended on September 30, 2019;
2. The Limited Review Report on Un-Audited Standalone and Consolidated Financial Results for the Quarter and Half Year Ended on September 30, 2019.
3. Financial Highlights for the Quarter and Half Year Ended on September 30, 2019.
Attachment
<< Back
Recently Viewed